BostonGene

United States
Waltham, Massachusetts, United States

Company profile

BostonGene company profile

BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies

Business identity

Phone number
+ 1-617-658-4545
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$1M-$10M
Founded
2015-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$200M
Last funding
Series B / $150M / 2022-04-06
Last equity funding
Series B / $150M
Investors
3
Lead investors
1
Founders
1
Articles
115

Founders and investors

Founders

Andrew Feinberg

Lead investors

NEC Corporation

Investors

Impact Investment CapitalJapan Industrial PartnersNEC Corporation